In a shocking about face the progress produced by the medical freedom movement, Attorney General Jeff Sessions has decided to undo the correct of individual states to put marijuana laws and instead will be subject to the dictates of your govt.
But more painful, Sessions proved both his hypocrisy and corruption when his DEA granted notorious pharmaceutical company Insys Therapeutics a virtual monopoly to create profits off of synthetic THC.
Jeff Sessions should give attention to how Congress crippled the DEA's capability to fight the opioid epidemic. Instead he tramples upon states' rights and recreational marijuana laws.
64,000 Americans died in 2009 from opioids. None have left from THC. But, you already know, priorities.
— Eugene Gu, MD (@eugenegu) January 4, 2018
A statement released on Thursday through the Department of Justice unveiled the revolutionary tyrannical philosophy:
It is the mission within the Department of Justice to enforce the laws of the usa, plus the previous issuance of guidance undermines the rule of law along with the ability of the local, state, tribal, and federal law enforcement officials partners to handle this mission.
“Therefore, todays memo on federal marijuana enforcement simply directs all U.S. Attorneys to make use of previously established prosecutorial principles that include them all the specified tools to disrupt criminal organizations, tackle the growing drug crisis, and thwart violent crime across our country.
But inside of a shocking (though unsurprising) display of pay-to-play, Session’s personal DEA—while classifying cannabis like a Schedule 1 drug—chose to classify the?synthetic THC drug Dronabinol, maded by pharmaceutical company Insys Therapeutics, as Schedule 2.
Effectively, this provides Insys a monopoly within the “free market” of medical THC, a move that likely comes from more than just coincidence if you think about the company’s long past of criminality.
2017 Opioid overdose deaths (est): 70,000+
2017 Marijuana/THC overdose deaths (est): 0
Sessions & GOP:
Give billions of federal regulations and tax breaks to pharmaceutical companies
Devote millions in federal prosecutorial spending to jailing potheads
— feminist to your neighbors (@emrazz) January 5, 2018
As?The Free Thought Project?reports:
“Those of you that dont know,?Insys?has grown to be notorious during couple of years after?six former executives and managers were arrested on charges they will involved in a nationwide scheme to bribe doctors to prescribe a drug containing the opioid fentanyl.
“Now this same gang of dangerous drug peddlers will be given a partial national monopoly about the sale of legal THC, because of the group who says he will protect Americans from drugs.
“Combined with executives, Michael Baich, the previous CEO, was?charged in the indictment filed in federal court.
“Perhaps the companys billionaire founder, John Kapoor was arrested in October for his role inside bribery scheme. He was freed on a $1 million bail after pleading blameless.”
Needless to suggest, the degree of corruption at play here can not be overstated, yet it’s not new for the medical freedom movement that has fought tirelessly for several years in this particular matter, and a lot more.
President Trump has consistently referenced the opioid epidemic sweeping the country, which might appear to be it ought to a lot higher priority than cracking concerning a harmless plant.
Indeed, the government financial aid October 2017, obama officially declared the opioid crisis a “national public health emergency”:
Effective today, my administration officially declared the #OpioidCrisis a NATIONAL PUBLIC HEALTH EMERGENCY under federal law. pic.twitter.com/YosOBurdCw
— Donald J. Trump (@realDonaldTrump) October 26, 2017
Sources:?The disposable Thought Project?Department of Justice